The Effect of Telomerase Enzyme on Cell Aging and Cancer Formation-Treatment
DOI:
https://doi.org/10.22399/ijcesen.403Keywords:
Telomerase, Telomere, Aging, CancerAbstract
Research has made the effects of the telomerase enzyme on both cellular ageing and cancer even more important. Measurement of telomerase activity appears to be a unique marker in addition to known methods for cancer diagnosis and treatment. In addition, numerous studies have shown that the reduction of telomeres shortens the life span of living cells. It is a known fact that cells with shortened lifespan age earlier and predispose to many diseases, especially cancer types. The fact that old cells are the basis for many diseases and young cells are resistant to many diseases has revealed the reality of keeping the cells young in order to prevent diseases. Studies aimed at understanding the activation of the telomerase enzyme on telomeres, have shown that this enzyme will have a positive effect on cellular rejuvenation on living cells, prolong the life span of living cells, thus preventing age-related diseases before they occur, and also making it impossible for many types of cancer that may develop due to old age to occur in the first place. Predictions such as preventing and stopping cellular senescence in human cells, providing cellular rejuvenation by reversing cellular senescence and extending human life span as much as desired are also worthy of further emphasis with the studies carried out.
References
Atlı, K., & Bozcuk, A. N. (2002). Telomerler ve hücresel yaşlanma. Geriatri, 5, 111-114.
Blasco, M. A. (2005). Telomeres and human disease: Aging, cancer and beyond. Nature Reviews Genetics, 6(8), 611-622.
McClintock, B. (1941). The stability of broken ends of chromosomes in Zea mays. Genetics, 41(3), 234-282.
Blackburn, E. (1991). Structure and function of telomeres. Nature, 350(6319), 569-572.
Smith, J. S., & Johnson, F. B. (2010). Isolation of G-quadruplex DNA using NMM-Sepharose affinity chromatography. In P. Baumann (Ed.), G-quadruplex DNA: Methods and protocols, Methods in Molecular Biology (Vol. 608, pp. 13). Humana Press. https://doi.org/10.1007/978-1-59745-363-9_13.
Murray, A. (1990). All’s well that ends well. Nature, 345(6274), 797-798.
Olovnikov, A. (1973). Theory of marginotomy. Journal of Theoretical Biology, 41(1), 181-190.
Morin, G. B. (1997). Telomere control of replicative lifespan. Experimental Gerontology, 32(4-5), 375-382.
Dikmen, G., & Doğan, P. (2003). Telomeraz ve kanser. Türkiye Klinikleri Journal of Medical Sciences, 23, 334-341.
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990). Telomeres shorten during ageing of human fibroblasts. Nature, 345(6274), 458-460.
Hayflick, L., & Moorhead, P. S. (1961). The serial cultivation of human telomerase activity diploid cell strains. Experimental Cell Research, 25, 585-621.
Bryan, T. M., & Reddel, R. R. (1997). Telomere dynamics and telomerase activity in in vivo immortalised human cells. European Journal of Cancer, 33(5), 767-773.
Banszerus, V. L., Vetter, V. N., Salewsky, B., König, M., & Demuth, I. (2019). Exploring the relationship of relative telomere length and the epigenetic clock in the LipidCardio cohort. International Journal of Molecular Sciences, 20(3032).
Shekhidem, H. A., Sharvit, L., Leman, E., Manov, I., Roichman, A., Holtze, S., Huffman, D. M., Cohen, H. Y., Hildebrandt, T. B., Shams, I., et al. (2019). Telomeres and longevity: A cause or an effect? International Journal of Molecular Sciences, 20(3233).
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994). Specific association of human telomerase activity with immortal cells and cancer. Science, 266(5193), 2011-2015.
Shay, J. W., & Wright, W. E. (1996). Telomerase activity in human cancer. Current Opinion in Oncology, 8(1), 66-71.
Kim, N. W. (1997). Clinical implications of telomerase in cancer. European Journal of Cancer, 33(5), 781-786.
Nakatani, K., Yoshimi, N., Mori, H., Yoshimura, S., Sakai, H., Shinoda, J., & Sakai, N. (1997). The significant role of telomerase activity in human brain tumors. Cancer, 80(3), 471-476.
Bednarek, A. K., Sahin, A., Brenner, A. J., Johnston, D. A., & Aldaz, C. M. (1997). Analysis of telomerase activity levels in breast cancer. Clinical Cancer Research, 3(1), 11-16.
Yoshida, K., Sugino, T., Tahara, H., Woodman, A., Bolodeoku, J., & Nargund, V. (1997). Telomerase activity in bladder carcinoma and its implication for noninvasive diagnosis by detection of exfoliated cancer cells in urine. Cancer, 79(4), 362-369.
Ito, H., Kyo, S., Kanaya, T., Takakura, M., Koshida, K., Namiki, M., & Inoue, M. (1998). Detection of human telomerase reverse transcriptase messenger RNA in voided urine samples as a useful diagnostic tool for bladder cancer. Clinical Cancer Research, 4(11), 2807-2810.
Kyo, S., Takakura, M., Kohama, T., & Inoue, M. (1997). Telomerase activity in human endometrium. Cancer Research, 57(4), 610-614.
Akbay, E., Contreras, C. M., Perera, S. A., Sullivan, J. P., Broaddus, R. R., Schorge, J. O., Raheela, A., Saboorian, H., Wong, K. K., & Castrillon, H. D. (2008). Differential roles of telomere attrition in type I and II endometrial carcinogenesis. American Journal of Pathology, 173(2), 536-544.
Veverka, P., Janovič, T., & Hofr, C. (2019). Quantitative biology of human shelterin and telomerase: Searching for the weakest point. International Journal of Molecular Sciences, 20(3186).
Wen, L., Zhao, C., Song, J., Ma, L., Ruan, J., Xia, X., Chen, E., Zhang, J., Ma, P. X., & Xu, J. (2020). CRISPR/Cas9-mediated TERT disruption in cancer cells. International Journal of Molecular Sciences, 21(653).
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 International Journal of Computational and Experimental Science and Engineering
This work is licensed under a Creative Commons Attribution 4.0 International License.
